Correction: Effectiveness of a Home-Based and Group-Based Tele-Exercise Program for Breast Cancer Survivors: Pilot Randomized Controlled Trial

• by Yang Gao, Yan Sun, Xueying Wang, Oi Kwan Chun, Brigitte Kim Yook Fung, Wai Wun Sara Fung

• November 11, 2026

Two ‘forever chemicals’ associated with higher risk of aggressive breast cancer in NIH analysis

• by Assistant Secretary for Public Affairs (ASPA)

• November 5, 2026

Can Immunopeptidomics Redefine Cancer Immunotherapy Development?

Immunopeptidomics is helping researchers identify tumor-presented antigens that could inform the development of targeted cell therapies and personalized cancer vaccines

• by Katherine Tran

• November 3, 2026

• 4 min

Publisher Correction: Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy

• by Florence Magrangeas, Mia Cherkaoui, Victor Bessonneau-Gaborit, Jennifer Derrien, Céline Chevalier, Catherine Guérin-Charbonnel, Benjamin Diamond, Mehmet Kemal Samur, Cyrille Hulin, Denis Caillot, Lionel Karlin, Bertrand Arnulf, Ola Landgren, Nikhil C. Munshi, Hervé Avet-Loiseau, Ludovic Martinet, Jill Corre, Aurore Perrot, Philippe Moreau, Cyrille Touzeau, Stéphane Minvielle, Eric Letouzé

• November 3, 2026